Johan van der Vlag, theme Renal disorders has been appointed professor of Immunology of Kidney Diseases and Transplantation at Radboud University/Radboud university medical center, with effect from 1 March 2020.
Johan van der Vlag is an expert in unravelling the molecular and immunological mechanisms underlying kidney disease and transplantation. His research stems from clinical questions and focuses on the development of new diagnostic/prognostic and therapeutic strategies, as well as valorisation of research findings. In addition to his research, he contributes to immunological education at both Radboud university medical center and the Faculty of Science, and he chairs the Examining Board of the Research Master's programme in Molecular Mechanisms of Disease at Radboud university medical center.
About Johan van der VlagJohan van der Vlag (Assen, 1965) studied molecular biology at the University of Groningen. He earned his PhD from the University of Amsterdam in 1994 with his research on molecular microbiology in the Department of Biochemistry. He then worked as a postdoc researcher at the Department of Food Technology at Wageningen University & Research, where he investigated pre- and probiotics in relation to the microbiome. He subsequently spent four years as a researcher in the Biochemistry department at the Swammerdam Institute for Life Sciences, a department of the University of Amsterdam, where he conducted pioneering research into molecular mechanisms that lead to epigenetic changes. Johan van der Vlag has been working at Radboud university medical center since 2000. Initially, he worked as a senior researcher in the Nephrology Research Laboratory, later as head of the Nephrology Research Laboratory and, since 2009, as associate professor of Experimental Nephrology. In 2010–2011, he was the Berlin visiting professor of diabetes in Israel (European Foundation for the Study of Diabetes).
He is a member of the Scientific Council of the Dutch Kidney Foundation, secretary of the science section of the Dutch Federation for Nephrology and coordinator of a number of national and international research consortia (GLYCOREN, GLYCOTREAT). He is also chair of the personal grant committee and advisor to the board of the Kidney Patient Association at Radboud university medical center.
Related news items
650,000 Euro funding for research into the phasing out of medication for leukaemia patients30 July 2020
With a 650,000 euro funding from ZonMw, researchers from the Haematology and Pharmacy departments can develop a medication phasing out strategy for patients with chronic myeloid leukaemia. This strategy will be tested in practice.read more
Increased role of patients after bowel cancer treatment30 July 2020
Approximately 14,000 patients get colorectal cancer every year. Almost all patients are operated on and monitored afterwards (follow-up). In 2019 Radboudumc started a new approach to follow-up research after the treatment of stage II/III colorectal cancer.read more
ERC Proof of Concept grant received by Ronald van Rij30 July 2020
Ronald van Rij, theme Infectious diseases and global health, received an ERC (European Research Council) Proof of Concept grant of 150,000 euros, in order to make arbovirus vaccines even safer.read more
Hypatia fellowship Call is open30 July 2020
The Hypatia fellowship round with the deadline 31 May has been canceled. Therefore, the next available deadline will be 27 September 2020. Radboudumc researchers are invited to scout young potentials to fill the strategic gaps within the research themes imbedded in RIHS and RIMLS.read more
Mihai Netea and colleagues published two papers back-to-back in The Journal of Clinical Investigation.29 July 2020
These back-to-back articles investigated the effect of BCG vaccination on trained immunity. The first article shows that BCG vaccination inhibits systemic inflammation, depending on gender. The second article demonstrates that the circadian rhythm influences the induction of trained immunity.read more
Genetic mutation reveals how coronavirus strikes TLR7 plays essential role in disease process28 July 2020
''Does a congenital immune defect play an important role in the defense against Coronavirus?'' This was published by Cas van der Made, Frank van der Veerdonk and Alexander Hoischen.read more